Recursion Pharmaceuticals, Inc. (RXRX)
Market Closed
3 Jun, 20:00
NASDAQ (NGS) NASDAQ (NGS) Primary 
XMEX $
3. 4700
-0.14
-3.88%
$
1.69B Market Cap
- P/E Ratio
- Div Yield
18,287,650 Volume
-1.72 Eps
$ 3.61
Previous Close Want to track RXRX and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
Recursion Pharmaceuticals, Inc. Investors
| Name | Quantity | Cost | Value | Profit ($) | Gain (%) |
|---|---|---|---|---|---|
| FG Fabian Guerra Guerra Advisors Inc. | 1,000 | $4,880 | $3,470 | -$1,410 | -28.89% |
| AIA AssuredPartners Investment Advisors LLC AssuredPartners Investment Advisors LLC | 23,133 | $92,228.7 | $80,271.51 | -$11,957.19 | -12.96% |
| PR Philippe Reitzer Banque Transatlantique SA | 924 | $5,003.94 | $3,206.28 | -$1,797.66 | -35.92% |
| GFM GF Fund Management Co. Ltd. GF Fund Management Co. Ltd. | 11,506 | $67,588.89 | $39,925.82 | -$27,663.07 | -40.93% |
| JCB John Ciaran Burns Universal-Beteiligungs- und Servicegesellschaft mbH | 227,663 | $1.11M | $789,990.61 | -$318,877.4 | -28.76% |
| AGI Ameriflex Group Inc. Ameriflex Group Inc. | 2,000 | $8,303.32 | $6,940 | -$1,363.32 | -16.42% |
